DOPAMINE D4 RECEPTOR ANTAGONISTS AS TREATMENT FOR ATTENTION DEFICIT-HYPERACTIVITY DISORDER

Details for Australian Patent Application No. 2002258506 (hide)

Owner THE MCLEAN HOSPITAL CORPORATION

Inventors BALDESSARINI, Ross, J.; ZHANG, Kehong; TARAZI, Frank, I.

Pub. Number AU-A-2002258506

PCT Pub. Number WO2002/072029

Priority 60/275,198 12.03.01 US

Filing date 12 March 2002

Wipo publication date 24 September 2002

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002258506

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002258507-SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE)

2002258505-COMPOSITIONS AND METHODS FOR MODIFYING THE CONTENT OF POLYUNSATURATED FATTY ACIDS IN MAMMALIAN CELLS